$ImmunoGen, Inc. (IMGN)$
May 16, 2018 5:01 PM EDT
ImmunoGen Announces Positive Findings from the FORWARD II Study of Mirvetuximab Soravtansine Combination Regimens with Avastin® and Carboplatin in Ovarian Cancer